Who are Tonix Pharmaceuticals Holding Corp.'s main suppliers?

Tonix Pharmaceuticals Holding Corp. (TNXP) key suppliers include: EVERANA. View the full supplier network at chainsifter.com/chain/TNXP.

Who are Tonix Pharmaceuticals Holding Corp.'s major customers?

Tonix Pharmaceuticals Holding Corp. (TNXP) key customers include: GROUP-PURCHASING-ORGANIZATION, CUSTOMERS, SPECIALTY-PHARMACIES, NATIONAL-PHARMACEUTICAL-WHOLESALERS, SPECIALTY-DISTRIBUTORS. View the full customer network at chainsifter.com/chain/TNXP.

What sector is Tonix Pharmaceuticals Holding Corp. in?

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

TNXP Supply Chain: Tonix Pharmaceuticals Holding Corp. Suppliers & Customers

1Suppliers

5Customers

3Debt Items

20Related Chains

Tonix Pharmaceuticals Holding Corp. Suppliers

Ticker	Name	Confidence	Evidence
EVERANA	EVERANA	90%	In 2024, Tonix engaged EVERSANA to support the launch strategy and commercial planning of TONMYA for the treatment of fibromyalgia.

Tonix Pharmaceuticals Holding Corp. Customers

Ticker	Name	Confidence	Evidence
GROUP-PURCHASING-ORGANIZATION	GROUP-PURCHASING-ORGANIZATION	92%	On May 6, 2026, Tonix Pharmaceuticals Holding Corp. (the “Company”) announced it entered into an agreement with a group purchasing organization (“GPO”) that provides coverage for TONMYA ® .
CUSTOMERS	CUSTOMERS	90%	For the three months ended March 31, 2026, revenues from three customers accounted for 30 %, 28 % and 18 % of net product revenues, respectively.
SPECIALTY-PHARMACIES	SPECIALTY-PHARMACIES	90%	Tonix has contracted with its existing wholesalers and specialty pharmacies for the distribution of TONMYA.
NATIONAL-PHARMACEUTICAL-WHOLESALERS	NATIONAL-PHARMACEUTICAL-WHOLESALERS	85%	TONMYA is distributed in the United States through national pharmaceutical wholesalers and specialty distributors pursuant to customary commercial arrangements.
SPECIALTY-DISTRIBUTORS	SPECIALTY-DISTRIBUTORS	85%	TONMYA is distributed in the United States through national pharmaceutical wholesalers and specialty distributors pursuant to customary commercial arrangements.

Tonix Pharmaceuticals Holding Corp. Debt Obligations

Instrument	Description	Confidence	Evidence
TNXP-DEBT	Debt stack $1.3M	90%	Market cache reports total debt of $1.3M.
TNXP-DEBT-13045	Warrants outstanding: 4.25	90%	xbrl warrant detail from xbrl 2024-12-31.
TNXP-DEBT-13046	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2013-12-31.

Tonix Pharmaceuticals Holding Corp. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tonix Pharmaceuticals Holding Corp..

Tonix Pharmaceuticals Holding Corp. Ownership

Holder	Name	Confidence	Evidence
TNXP-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 82 tracked holders.

Tonix Pharmaceuticals Holding Corp. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ALLO	Allogene Therapeutics, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
ALC	Alcon Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
CCCC	C4 Therapeutics, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
AORT	Artivion, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
DEO	Diageo plc	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
AUTL	Autolus Therapeutics plc	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2

Tonix Pharmaceuticals Holding Corp. Supply Chain